Evolent Health, Inc. (EVH)

NYQ – Цена в реальном времени. Валюта: USD

5.51

+0.48 (9.54%)

При закрытии: Jun 26, 2026, 4:00 PM EDT

5.39

-0.12 (-2.18%)

После закрытия: Jun 26, 2026, 7:37 PM EDT

18.05.2026

Agentic AI Powers U.S. Healthcare Stocks

Healthcare payrolls keep climbing, and hospital systems, payers, and clinics are now openly treating agentic AI as the cheapest unit of labor on the market.

10.05.2026

Evolent Health Q1 Earnings Call Highlights

Evolent Health NYSE: EVH reported first-quarter 2026 results that management said were in line with expectations, while reiterating its full-year outlook and highlighting new contract wins, early progress on major client launches and continued investment in automation.

08.05.2026

Evolent Health, Inc. (EVH) Q1 2026 Earnings Call Transcript

07.05.2026

Compared to Estimates, Evolent Health (EVH) Q1 Earnings: A Look at Key Metrics

While the top- and bottom-line numbers for Evolent Health (EVH) give a sense of how the business performed in the quarter ended March 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

07.05.2026

Evolent Health (EVH) Reports Q1 Loss, Misses Revenue Estimates

Evolent Health (EVH) came out with a quarterly loss of $0.02 per share versus the Zacks Consensus Estimate of a loss of $0.05. This compares to earnings of $0.06 per share a year ago.

07.05.2026

Evolent Announces First Quarter 2026 Results

WASHINGTON, May 7, 2026 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH) ("Evolent" or the "Company"), a company that specializes in better health outcomes for people with complex conditions through proven solutions that make health care simpler and more affordable, today announced financial results for the three months ended March 31, 2026. Seth Blackley, Co-Founder and Chief Executive Officer of Evolent stated, "I am happy with the strong start to the year.

07.04.2026

Evolent To Release First Quarter 2026 Financial Results on Thursday, May 7, 2026

WASHINGTON, April 7, 2026 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a company focused on achieving better health outcomes for people with complex conditions, today announced it will release its first quarter 2026 financial results on Thursday, May 7, 2026, before market open, with a conference call to follow at 8 a.m. ET. Shareholders and interested participants may listen to a live broadcast of the conference call found on Evolent's investor relations website, https://ir.evolent.com.

Видео

No Data

There is no data to display

Пресс-релизы

07.05.2026

Evolent Announces First Quarter 2026 Results

19.03.2026

Evolent announces appointment of Archie Mayani as chief product officer

Industry veteran brings track record of innovation from GHX, Change Healthcare, UnitedHealth Group and Amazon. WASHINGTON, March 19, 2026 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a company focused on achieving better health outcomes for people with complex conditions, today announced the appointment of health care technology leader and AI innovator Archie Mayani as chief product officer (CPO).

24.02.2026

Evolent Announces Fourth Quarter 2025 Results and Full Year 2025 Results

WASHINGTON, Feb. 24, 2026 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH) ("Evolent" or the "Company"), a company that specializes in better health outcomes for people with complex conditions through proven solutions that make health care simpler and more affordable, today announced financial results for the three months ended December 31, 2025. Seth Blackley, Co-Founder and Chief Executive Officer of Evolent stated, "In 2025 we executed on our earnings targets, continued to grow market share, renewed customers at strong rates, and continued the migration of Performance Suite clients to our enhanced Performance Suite contract model.

02.01.2026

Evolent Reports Inducement Award Under NYSE Listing Rule 303A.08

WASHINGTON, Jan. 2, 2026 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH) ("Evolent" or the "Company"), a company that specializes in better health outcomes for people with complex conditions through proven solutions that make health care simpler and more affordable, announced that the Compensation Committee of Evolent's Board of Directors approved the grant of a one-time time-based restricted stock unit award covering 587,500 shares of Evolent Class A common stock, par value $0.01 per share (the "Inducement Award"), to Mr. Mario Ramos ("Mr.

Evolent Health, Inc. (EVH)

Получите доступ ко всем премиум-функциям лучшего инструмента для анализа акций

Finranks

Компания

Контакты

Мы в соцсетях

Evolent Health, Inc. (EVH)

Agentic AI Powers U.S. Healthcare Stocks

Evolent Health Q1 Earnings Call Highlights

Evolent Health, Inc. (EVH) Q1 2026 Earnings Call Transcript

Compared to Estimates, Evolent Health (EVH) Q1 Earnings: A Look at Key Metrics

Evolent Health (EVH) Reports Q1 Loss, Misses Revenue Estimates

Evolent Announces First Quarter 2026 Results

Evolent To Release First Quarter 2026 Financial Results on Thursday, May 7, 2026

Видео

No Data

Пресс-релизы

Evolent Announces First Quarter 2026 Results

Evolent announces appointment of Archie Mayani as chief product officer

Evolent Announces Fourth Quarter 2025 Results and Full Year 2025 Results

Evolent Reports Inducement Award Under NYSE Listing Rule 303A.08

Agentic AI Powers U.S. Healthcare Stocks

Evolent Health Q1 Earnings Call Highlights

Evolent Health, Inc. (EVH) Q1 2026 Earnings Call Transcript

Compared to Estimates, Evolent Health (EVH) Q1 Earnings: A Look at Key Metrics

Evolent Health (EVH) Reports Q1 Loss, Misses Revenue Estimates

Evolent Announces First Quarter 2026 Results

Evolent To Release First Quarter 2026 Financial Results on Thursday, May 7, 2026

Видео

No Data

Пресс-релизы

Evolent Announces First Quarter 2026 Results

Evolent announces appointment of Archie Mayani as chief product officer

Evolent Announces Fourth Quarter 2025 Results and Full Year 2025 Results

Evolent Reports Inducement Award Under NYSE Listing Rule 303A.08

Search stocks

Evolent Health, Inc. (EVH)

Получите доступ ко всем премиум-функциям лучшего инструмента для анализа акций

Finranks

Компания

Контакты

Мы в соцсетях

Evolent Health, Inc. (EVH)

Agentic AI Powers U.S. Healthcare Stocks

Evolent Health Q1 Earnings Call Highlights

Evolent Health, Inc. (EVH) Q1 2026 Earnings Call Transcript

Compared to Estimates, Evolent Health (EVH) Q1 Earnings: A Look at Key Metrics

Evolent Health (EVH) Reports Q1 Loss, Misses Revenue Estimates

Evolent Announces First Quarter 2026 Results

Evolent To Release First Quarter 2026 Financial Results on Thursday, May 7, 2026

Видео

No Data

Пресс-релизы

Evolent Announces First Quarter 2026 Results

Evolent announces appointment of Archie Mayani as chief product officer

Evolent Announces Fourth Quarter 2025 Results and Full Year 2025 Results

Evolent Reports Inducement Award Under NYSE Listing Rule 303A.08

Agentic AI Powers U.S. Healthcare Stocks

Evolent Health Q1 Earnings Call Highlights

Evolent Health, Inc. (EVH) Q1 2026 Earnings Call Transcript

Compared to Estimates, Evolent Health (EVH) Q1 Earnings: A Look at Key Metrics

Evolent Health (EVH) Reports Q1 Loss, Misses Revenue Estimates

Evolent Announces First Quarter 2026 Results

Evolent To Release First Quarter 2026 Financial Results on Thursday, May 7, 2026

Видео

No Data

Пресс-релизы

Evolent Announces First Quarter 2026 Results

Evolent announces appointment of Archie Mayani as chief product officer

Evolent Announces Fourth Quarter 2025 Results and Full Year 2025 Results

Evolent Reports Inducement Award Under NYSE Listing Rule 303A.08